Christopher D Verrico

Verrico

Christopher D Verrico, Ph.D.

Associate Professor

(713) 791-1414

Email

verrico@bcm.edu

Positions

Associate Professor: Psychiatry Research
Baylor College of Medicine
Houston, TX, US

Addresses

Michael E. DeBakey Veterans Affairs Medical Center (Office): 2002 Holcombe Blvd
Building 100
Houston, TX, 77030
United States
Phone: (713) 791-1414
verrico@bcm.edu

Education

Postdoctoral Fellowship at University Of Pittsburgh: Pittsburgh, Pennsylvania, United States; Department of Psychiatry, Translational Neuroscience Program

Postdoctoral Fellowship at Carnegie Mellon University: Pittsburgh, Pennsylvania, United States; Search Results Web Result with Site Links Center for Neural Basis of Cognition

Postdoctoral Fellowship at Harvard Medical School: Southborough, Massachusetts, United States; Department of Psychiatry, Division of Neurochemistry

Postdoctoral Fellowship at Yale University School Of Medicine: New Haven, Connecticut, United States; Department of Psychiatry

BS from University Of Pittsburgh: 01/1995 - Pittsburgh, Pennsylvania, United States; Neuroscience

PhD from Yale University: 01/2002 - New Haven, Connecticut, United States; Pharmacology

Websites

VIICTR Publications List

Selected Publications

Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA.. " Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. " American J Psychiatry. 2014 Apr ; 171 (4) : 416-25.
Pubmed PMID: 24577206.
Verrico CD, Liu S, Bitler EJ, Gu H, Sampson AR, Bradberry CW, Lewis DA. " Delay- and dose-dependent effects of d(9)-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys. " Neuropsychopharmacology. 2012 May ; 37 (6) : 1357-66.
Pubmed PMID: 22218091.
Verrico CD, Liu S, Asafu-Adjei JK, Sampson AR, Bradberry CW, Lewis DA. " Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys. " Brain Res.. 2011 Mar 10; 1378 : 91-104.
Pubmed PMID: 21215729.
Volk DW, Siegel BI, Verrico CD, Lewis DA. " Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. " Schizophr. Res.. 2013 Jun ; 147 (1) : 53-7.
Pubmed PMID: 23561296.
Eggan SM, Stoyak SR, Verrico CD, Lewis DA. " Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. " Neuropsychopharmacology. 2010 Sep ; 35 (10) : 2060-71.
Pubmed PMID: 20555313.
Verrico CD, Jentsch JD, Roth RH, Taylor JR. " Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. " Neuropsychopharmacology. 2004 Mar ; 29 (3) : 522-9.
Pubmed PMID: 14694348.
Verrico CD, Jentsch JD, Roth RH. " Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. " Synapse. 2003 Jul ; 49 (1) : 61-6.
Pubmed PMID: 12710016.
Verrico CD, Jentsch JD, Dazzi L, Roth RH. " Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat. " Synapse. 2003 Jun 15; 48 (4) : 178-83.
Pubmed PMID: 12687636.
Jentsch JD, Dazzi L, Chhatwal JP, Verrico CD, Roth RH. " Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. " Neurosci. Lett.. 1998 Dec 24; 258 (3) : 175-8.
Pubmed PMID: 9885959.
Jentsch JD, Verrico CD, Le D, Roth RH. " Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. " Neurosci. Lett.. 1998 May 1; 246 (3) : 169-72.
Pubmed PMID: 9792619.
George TP, Picciotto MR, Verrico CD, Roth RH. " Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects. " Biol. Psychiatry. 2001 Feb 1; 49 (3) : 300-6.
Pubmed PMID: 11230881.
George TP, Verrico CD, Xu L, Roth RH. " Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms. " Neuropsychopharmacology. 2000 Jul ; 23 (1) : 79-88.
Pubmed PMID: 10869888.
George TP, Verrico CD, Picciotto MR, Roth RH. " Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. " J. Pharmacol. Exp. Ther.. 2000 Oct ; 295 (1) : 58-66.
Pubmed PMID: 10991961.
George TP, Verrico CD, Roth RH. " Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. " Brain Res.. 1998 Aug 10; 801 (41276) : 36-49.
Pubmed PMID: 9729261.
Verrico CD, Lynch L, Fahey MA, Fryer AK, Miller GM, Madras BK. " MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. " J. Psychopharmacol. (Oxford). 2008 Mar ; 22 (2) : 187-202.
Pubmed PMID: 18308800.
Verrico CD, Miller GM, Madras BK. " MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. " Psychopharmacology (Berl.). 2007 Jan ; 189 (4) : 489-503.
Pubmed PMID: 16220332.
Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK. " Primate trace amine receptor 1 modulation by the dopamine transporter. " J. Pharmacol. Exp. Ther.. 2005 Jun ; 313 (3) : 983-94.
Pubmed PMID: 15764732.
Verrico CD, Mahoney JJ 3rd, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R 2nd. " Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. " Int J Neuropsychopharmacol. 2014 Feb ; 17 (2) : 223-33.
Pubmed PMID: 24393456.
Verrico CD, Haile CN, Mahoney JJ 3rd, Thompson-Lake DG, Newton TF, De La Garza R 2nd. " Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. " Drug Alcohol Depend.. 2014 Aug ; 141 : 72-8.
Pubmed PMID: 24928479.
Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R 2nd.. " Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. " Expert Opin Investig Drugs. 2013 ; 22 (12) : 1549-68.
Pubmed PMID: 24033127.

Log In to edit your profile